Christopher B. Hansen

Christopher B. Hansen, MD, serves as a Clinical Associate Professor in the Department of Dermatology at the University of Utah School of Medicine, providing specialized care at Midvalley Health Center in Murray, Utah. Board-certified by the American Board of Dermatology, he directs the UVA-1 phototherapy program for sclerosing skin disorders and manages complex rheumatic skin conditions including lupus erythematosus, dermatomyositis, and scleroderma alongside common dermatological issues like acne and skin cancer.

His academic training includes a B.A. in French and M.D. from the University of Utah, followed by an Internal Medicine internship at the same institution. He completed his Dermatology residency at the University of Texas Southwestern (serving as Chief Resident) and a Dermatology research fellowship at the University of Utah.

• B.A. in French: University of Utah
• M.D.: University of Utah School of Medicine
• Internal Medicine Internship: University of Utah
• Dermatology Residency: University of Texas Southwestern (Chief Resident)
• Dermatology Research Fellowship: University of Utah

Dr. Hansen's research centers on autoimmune and connective tissue skin diseases, with particular focus on pathophysiology and treatment of lupus variants, dermatomyositis, and morphea. His clinical expertise extends to phototherapy applications and management of drug-induced dermatological conditions, informed by both his 15-year publication record and daily patient interactions. He emphasizes evidence-based approaches for complex cases involving overlapping rheumatologic and dermatological manifestations.

Analysis of his 15 most recent publications (2010-2025) reveals consistent thematic focus on autoimmune skin disorders, with increasing attention to patient-centered outcomes and treatment safety. Key trends include investigation of drug-induced conditions (e.g., vaccine-associated dermatomyositis), quality-of-life metrics in bullous diseases, and refinement of phototherapy protocols for sclerosing disorders. His collaborative work with University of Utah colleagues demonstrates integration of rheumatology, oncology, and psychodermatology perspectives.

Dr. Hansen runs the UVA-1 phototherapy program within the Department of Dermatology, specializing in treatment of morphea and related sclerosing conditions. Patient testimonials consistently highlight his exceptional clinical approach characterized by thorough explanation of treatment options, unhurried appointments, and genuine concern for patient perspectives - reflected in his 5.0/5 rating from over 1,161 reviews. His practice philosophy emphasizes shared decision-making and comprehensive addressing of all patient concerns during consultations.